NCT05305534 - QIAstat-Dx® BCID Plus AMR Panels Clinical Performance Study | Biotech Hunter

Enrollment

2,142

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

April 10, 2025

Study Completion Date

August 25, 2025

Conditions

Blood Disease

Interventions

DEVICE

QIAstat-Dx® BCID GN and GPF Plus AMR Panels

The performance of QIAstat-Dx® BCID GN and GPF Plus AMR Panels will be evaluated in comparison with another validated comparator method, using residual specimens of positive blood culture. Pure colonies derived from the residual positive blood culture specimens will also be tested

Trial Locations (1)

Unknown

QIAGEN, Manchester

All Listed Sponsors

lead

QIAGEN Gaithersburg, Inc

INDUSTRY